Obstetrics & gynaecology

Most infants with RSV-related critical illness born at term

Most infants requiring intensive care for respiratory syncytial virus are born at term, and do not have underlying medical conditions, according to a study published online Aug. 15 in JAMA Network Open.

Pediatrics

CDC recommends RSV shot for all infants

The U.S. Centers for Disease Control and Prevention on Thursday recommended that all infants under the age of 8 months be given a new antibody shot to help guard against severe respiratory syncytial virus (RSV).

Vaccination

GSK sues Pfizer over patents for RSV vaccine

GlaxoSmithKline sued Pfizer on Wednesday over patent infringement, alleging the US drugmaker's RSV vaccine steals key elements of the British company's version.

Diseases, Conditions, Syndromes

Q&A: What's in store for the upcoming respiratory virus season?

Last year's "tripledemic" of flu, COVID-19 and RSV left many of us wary of what the coming respiratory virus season might bring. But this year's landscape is already different, with new vaccines and treatments, like the game-changing ...

page 7 from 26